Proyectos Internacionales - IIS Aragón 📋🔬
Enero 2023
La oficina de proyectos internacionales del IIS Aragón ha creado este boletín mensual mediante el cual se va a informar de las convocatorias de proyectos que se encuentran abiertas, los eventos y las jornadas que puedan resultar interesantes al respecto para el personal investigador y de gestión. 

Si quieres contactar con la oficina de proyectos internacionales puedes hacerlo a través de esta dirección de correo electrónico
Convocatorias actuales

Abierto hasta finalizar fondos
ISIDORe: Preparedness programme calls for proposals

The ISIDORe project proposes to fund Research & Development into preparedness and responsiveness, by giving scientific communities, free-of-charge transnational access (TNA) to the whole extent of our state-of-the-art facilities, cutting-edge services, advanced equipment and technologies, made available through our catalogue of services.

Calls available:
- SARS-CoV-2 & COVID‑19: Open as long as funding remains available.
Risk Group 4 Pathogens: 07 February 2023, 23.59 CET (for access to BSL-4 capacities)
Respiratory Pathogens: Open as long as funding remains available.
Vector-Borne Pathogens and their Vectors: Open as long as funding remains available.
Other Pathogens with epidemic potential: Open as long as funding remains available.

For more information:
•    List of ISIDORe Priority Preparedness pathogens
•    Research scope
•    Limitations
•    Preparedness calls for proposals


IARC Summer School 2023 Call for Applications is Open

The International Agency for Research on Cancer (IARC) is pleased to announce that it is now accepting applications for the IARC Summer School 2023, for two modules: "Introduction to Cancer Epidemiology" and "Implementing Cancer Prevention and Early Detection".
The IARC Summer School 2023 provides the opportunity to stimulate cancer research, improve scientific knowledge, and develop collaborations among researchers worldwide. Building on past successful IARC Summer Schools, the two modules in 2023 will be delivered as blended training programmes, combining online learning with virtual and in-person classes. The hybrid format will offer the best of remote learning and the unmatched value of relationships formed during face-to-face events and their effect on boosting network-building and future collaborations.
Those who want to attend the summer school module on "Implementing Cancer Prevention and Early Detection" should first take the self-paced course on cancer prevention and early detection, which is available on the IARC Learning portal. This self-paced learning path will take participants through various resources, which cover the basic concepts and principles related to cancer prevention and early detection. See the links below for more information.

IARC Summer School 2023
Self-paced course on cancer prevention and early detection


Horizon Europe – ERC Proof of Concept Grant

Horizon Europe – ERC Proof of Concept Grant (ERC-2023-POC)
The ERC Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research, by funding further work (i.e. activities which were not scheduled to be funded by the original ERC frontier research grant) to verify the innovation potential of ideas arising from ERC funded projects. Proof of Concept Grants are therefore on offer only to Principal Investigators whose proposals draw substantially on their ERC funded research.

The financial contribution will be awarded as a lump sum of EUR 150 000 for a period of 18 months. The ERC expects that, normally, proof of concept activities should be completed within 12 months. However, to allow for those projects that require more preparation time, the grant agreements will be signed for 18 months. Extensions of the duration of proof of concept projects may be granted only exceptionally.The lump sum will cover the beneficiaries' direct and indirect eligible costs for the project: if the project is implemented properly, the amounts will be paid regardless of the costs actually incurred. The lump sum has been designed to cover the beneficiaries’ personnel costs, subcontracting, purchase costs, other cost categories, and indirect costs.

All Principal Investigators in an ongoing ERC main grant or in a ERC main grant that has ended less than 12 months before 1 January 2023, are eligible to apply for an ERC Proof of Concept Grant.

For further information please see the ERC Work Programme 2023.





ATTRACT-Call: Accelerate Together Rare Cancer Treatment

Cinco fondos europeos contra el cáncer, entre los que se encuentra la Fundación Científica de la Asociación Española Contra el Cáncer, se unen para estimular la investigación internacional para el desarrollo de fármacos contra cánceres raros.
Esta convocatoria internacional conjunta, ATTRACT-Call, se centra en ensayos clínicos de fase 2/3 de medicamentos contra cánceres raros, y cuenta con 11,5 M€ de presupuesto.

-  Mejorar el tratamiento de los cánceres raros
-   Llevar los fármacos a la siguiente fase de Desarrollo

Para más información pincha aquí.



Horizon Europe – ERC Consolidator Grant

The ERC Consolidator Grants are designed to support excellent Principal Investigators at the career stage at which they may still be consolidating their own independent research team or programme. Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal.
Consolidator Grants may be awarded up to a maximum of EUR 2 000 000 for a period of 5 years. The maximum size of the grants is reduced pro rata temporis for projects of a shorter duration. (This does not apply to ongoing projects).
The Principal Investigators shall have been awarded their first PhD at least 7 and up to 12 years prior to 1 January 2023. Cut-off dates: PhD awarded from 1 January 2011 to 31 December 2015 (inclusive).

For more information, click here.





ERA4Health Partnership – Convocatoria CARDINNOV
Convocatoria de Proyectos Transnacionales con participación de la Agencia Estatal de Investigación en el marco de “ERA4Health Partnership”.
España participa en la segunda convocatoria transnacional de la iniciativa ERA4Health Partnership “Fostering a European Research Area for Health”, a través de la Agencia Estatal de Investigación (AEI), el Instituto de Salud Carlos III (ISCIII) y la Consejería de Salud y Consumo de la Junta de Andalucía (CSCJA). 

El objetivo general de la convocatoria es apoyar la investigación transversal que contribuya al desarrollo de estrategias de innovación terapéutica en enfermedades cardiovasculares, abordando alguna (o ambas) de las siguientes áreas de investigación:

1- Reparación y/o regeneración del corazón y/o de los vasos sanguíneos.
2-Insuficiencia cardíaca crónica y fibrilación auricular.

Para más información pincha aquí.





European Join Programmes on Rare Diseases

Call for Proposals 2023 : «Natural History Studies addressing unmet needs in Rare Diseases”
The objective of this call is to conduct efficient, innovative and high-quality natural history studies which will facilitate understanding of the disease’s or group of disorders’ progression throughout the lifespan of a patient. The goal of these studies is to collect and analyze comprehensive patient data to define targets for future therapies, taking into consideration innovation, safety, and efficacy.

Research proposals should cover at least one of the following areas:
1-   Estimation of disease prevalence;
2-  Identification of biomarkers/companions for the diagnosis/prognosis of a RD;
3-   Identification of biomarkers/indicators/predictors of a rare disease or group of disorders (e.g. having the same aetiology) onset/progression (including collection of genetic, physiological, environmental data or variables….);
4-   Identification of relevant endpoints for future studies that include potential biomarkers, querying patient-reported outcomes (PROs) and quality-of-life measures;
5-   Identification of biomarkers/variables for therapeutic approaches (pharmacology, drug repurposing, gene therapy, RNA therapy, cell therapy, medical devices…).

For more information, click here.



Horizon Europe – MSCA COFUND 2022 (HORIZON-COFUND-2022-01-01)

MSCA COFUND co-finances new or existing doctoral programmes and postdoctoral fellowship schemes with the aim of spreading the best practices of the MSCA including international, inter-sectoral and interdisciplinary research training, as well as international and cross-sectoral mobility of researchers at all stages of their career.
In practice, MSCA COFUND provides complementary funding for doctoral or postdoctoral programmes managed by entities established in EU Member States or Horizon Europe Associated Countries. Those co-funded programmes must follow MSCA’s good practice in terms of international recruitment and minimum standard of employment for the recruited fellows as described in the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers.
Opening date: 11/10/2022

For more information, click here.



EU4HEALTH Work Programme 2022 (EU4H-2022-PJ)

EU4H-2022-PJ-15: Call for proposals to support structured dialogue at national or regional level on public procurement in the health sector - HERA

For more information, please find here the EU4H Work Programme 2022.



EU4HEALTH Work Programme 2022 (EU4H-2022-PJ)

EU4H-2022-PJ-11: Call for proposals on prevention of NCDs - cardiovascular diseases, diabetes and other NCDs
EU4H-2022-PJ-12: Call for proposals on cancer and other NCDs prevention – action on health determinants
EU4H-2022-PJ-14: Call for proposals to support the roll-out of the second cohort of the inter-speciality cancer training programme






Call for proposals for Mechanisms of Resilience and Vulnerability to Environmental Challenges in Mental Health.

The aim of the call is to facilitate multinational, collaborative research projects that will address critical translational questions to improve our knowledge concerning neurobiological mechanisms involved in resilience or vulnerability to environmental challenges in mental health.

For more information, click here.






(Call opens 10 January 2023) AMR Diagnostics and Surveillance 2023

Proposals should aim to address unmet needs in the AMR diagnostics and surveillance sectors beyond the current state of the art, by focusing on one of the topics of the call:

•  Topic 1: To develop novel, or improve existing, diagnostics, including point of care diagnostics, that can rule out antimicrobial use or help identify the most effective antimicrobial treatment.
•   Topic 2: To develop or improve existing strategies, technologies or methods, or data use strategies to support One Health AMR surveillance.

For more information click here.



Horizon Europe – MSCA Staff Exchanges 2022 (HORIZON-MSCA-2022-SE-01-01

MSCA Staff Exchanges promote innovative international, inter-sectoral and interdisciplinary collaboration in research and innovation through exchanging staff and sharing knowledge and ideas at all stages of the innovation chain. The scheme fosters a shared culture of research and innovation that welcomes and rewards creativity and entrepreneurship and helps turn ideas into innovative products, services or processes. It is open to research, technical, administrative, and managerial staff supporting R&I activities.

For more information, click here.



Horizon Europe – Research infrastructure services to support health research, accelerate the green and digital transformation, and advance frontier knowledge (2023) (INFRASERV

HORIZON-INFRA-2023-SERV-01-01: Research infrastructure services to enable R&I addressing main challenges and EU priorities.

For RI services for improving clinical research in the paediatric area
•    advancement of paediatric medicines and other therapeutic and diagnostic approaches for this population group to markets and towards clinical use;
•    accelerated availability of solutions and products to paediatric patients in need;
•    wider access to rationally designed RI services across Europe to underpin the competitiveness of the European industry and of biotech SMEs developing paediatric medicines and treatment and diagnostic devices;
•    joining forces of research infrastructures and paediatric competence networks in EU Member States and Associated Countries, to facilitate paediatric research in the context of pertinent EU regulatory environment;
•    availability of innovative tools to conduct paediatric clinical trials, for the re-use of population and historical data, and for enhanced data sharing across actors at different care levels and across regions in Europe.



ERA4Health JTC1 HealthEquity

ERA4Health Call for transnational research proposals “Increasing health equity through promoting healthy diets and physical activity (HealthEquity)

The aim of this call is to develop novel strategies and targeted approaches to identify, understand, and modify determinants and mechanisms of diet-related behaviour and physical activity as well as sedentary behaviour, which have the potential to break through the cycles maintaining unhealthy behaviours and lifestyles and to reduce health inequalities.

The call will be announced on 13/01/2023 and the submission system will be open on the same day.

Further information



Horizon Europe – Innovative Health Initiative call 3 (HORIZON-JU-IHI-2022-03-single-stage

•    HORIZON-JU-IHI-2022-03-01: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need
•    HORIZON-JU-IHI-2022-03-02: Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation
•    HORIZON-JU-IHI-2022-03-03: Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency
•    HORIZON-JU-IHI-2022-03-04: Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases
•    HORIZON-JU-IHI-2022-03-05: Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences.

Los consorcios solicitantes deben asegurarse de que al menos un 45% del presupuesto total está cubierto por las contribuciones de los participantes en el proyecto.


EU4HEALTH Work Programme 2022

•    EU4H-2022-PJ-16: Call for proposals to support Member States and other relevant actors to implement relevant results of innovative public health research in relation to vaccination against COVID-19.


Horizon Europe – Mission on Cancer

•    HORIZON-MISS-2023-CANCER-01-01: Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients.
•    HORIZON-MISS-2023-CANCER-01-02: Enhance primary cancer prevention through sustainable behavioural change.
•    HORIZON-MISS-2023-CANCER-01-03: Pragmatic clinical trials on minimally invasive diagnostics
•    HORIZON-MISS-2023-CANCER-01-04: Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions.



Horizon Europe – Clúster Salud

Staying Healthy (Single stage -2023) (HORIZON-HLTH-2023-STAYHLTH-01)
•    HORIZON-HLTH-2023-STAYHLTH-01-01: The Silver Deal – Person-centred health and care in Europe regions.

Environment and health (Single stage -2023) (HORIZON-HLTH-2023-ENVHLTH-02)

•    HORIZON-HLTH-2023-ENVHLTH-02-01: Planetary health: understanding the links between environmental degradation and health impacts.
•    HORIZON-HLTH-2023-ENVHLTH-02-02: Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces)
•    HORIZON-HLTH-2023-ENVHLTH-02-03: Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties.
•    HORIZON-HLTH-2023-ENVHLTH-02-04: Global coordination of exposome research.

Tackling diseases (Single stage – 2023) (HORIZON-HLTH-2023 DISEASE-03)

•    HORIZON-HLTH-2023-DISEASE-03-01: Novel approaches for palliative and end-of-life care for non-cancer patients.
•    HORIZON-HLTH-2023-DISEASE-03-03: Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases – GACD)
•    HORIZON-HLTH-2023-DISEASE-03-04: Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential.
•    HORIZON-HLTH-2023-DISEASE-03-05: Pandemic preparedness and response: Sustaining established coordination mechanisms for European adaptive platforms trials and/or for cohort networks.
•    HORIZON-HLTH-2023-DISEASE-03-06: Towards structuring brain health research in Europe.
•    HORIZON-HLTH-2023-DISEASE-03-07: Relationship between infections and non-communicable diseases.
•    HORIZON-HLTH-2023-DISEASE-03-17: Pandemic preparedness and response: Understanding vaccine induced-immunity.
•    HORIZON-HLTH-2023-DISEASE-03-18: Pandemic preparedness and response: Immunogenecity of viral proteins of viruses with epidemic and pandemic potential.

Ensuring access to innovative, sustainable and high-quality health care (Single stage -2023) (HORIZON-HLTH-2023-CARE-04)

•    HORIZON-HLTH-2023-CARE-04-01: Maintaining access to regular health and care services in case of cross-border emergencies.
•    HORIZON-HLTH-2023-CARE-04-02: Resilience and mental wellbeing of the health and care workforce.
•    HORIZON-HLTH-2023-CARE-04-03: Environmentally sustainable and climate neutral health and care systems.

Tools and technologies for a healthy society (Single stage – 2023) (HORIZON-HLTH-2023-TOOL-05)

•    HORIZON-HLTH-2023-TOOL-05-01: Clinical trials of combined Advance Therapy Medicinal Products (ATMPs)
•    HORIZON-HLTH-2023-TOOL-05-03: Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management.
•    HORIZON-HLTH-2023-TOOL-05-04: Better integration and use of health-related real-world and research data, including genomics, for improved clinical outcomes.
•    HORIZON-HLTH-2023-TOOL-05-05: Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery.
•    HORIZON-HLTH-2023-TOOL-05-08: Pandemic preparedness and response: in vitro diagnostic devices to tackle cross-border health threats.
•    HORIZON-HLTH-2023-TOOL-05-09: Developing a Data Quality and Utility Label for the European Health Data Space.

A competitive health-related industry (Single stage – 2023) (HORIZON-HLTH-2023-IND-06)

•    HORIZON-HLTH-2023-IND-06-01: Supporting the uptake of innovative Health Technology Assessment (HTA) methodology and advancing HTA expertise across EU.
•    HORIZON-HLTH-2023-IND-06-02: Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space.
•    HORIZON-HLTH-2023-IND-06-04: Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines.
•    HORIZON-HLTH-2023-IND-06-05: Mapping the hurdles for the clinical applications of Advanced Therapy Medicinal Products (ATMPs).
•    HORIZON-HLTH-2023-IND-06-07: Development and harmonisation of methodologies for assessing digital health technologies in Europe.



Horizon Europe – Innovative Health Initiative call 4 (HORIZON-JU-IHI-2022-04-two stages)

•    Topic 1: Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment
•    Topic 2: Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare



Proyectos multinacionales de Investigación sobre Aspectos Éticos, Legales y Sociales (ELSA) de la Neurociencia.

Las propuestas de investigación podrán abordar, entre otros, los siguientes temas:

* Consecuencias del desarrollo de los métodos neurocientíficos de diagnóstico.
* Diagnóstico en ausencia de opciones de tratamiento; interacciones entre pacientes socioculturalmente diversos y el personal sanitario; acceso (equitativo) a métodos novedosos y caros; uso no intencionado y/o uso indebido).
* Aspectos de investigación clínica con pacientes que padecen enfermedades neurológicas o psiquiátricas.
* Tecnologías inteligentes y estrecha interacción entre el ser humano y la máquina.
* Biobancos de tejidos neuronales.
* Utilización de datos cerebrales; intervenciones cerebrales en contextos jurídicos.
* Impacto de la neurociencia moderna en las cuestiones, conceptos y teorías filosóficas tradicionales sobre aspectos fundamentales de la naturaleza humana.
* Cambios sociales y culturales inducidos por el conocimiento neurocientífico y su aplicación.
* Investigación e innovación responsables en neurotecnología y neurociencia.

Más información aquí.


Horizon Europe – Partnerships in Health (2023) (HORIZON-HLTH-2023-DISEASE-07)

•    HORIZON-HLTH-2023-DISEASE-07-01: European Partnership on Rare Diseases. Programme Cofund Actions.
Planned opening date: 12 January 2023


Horizon Europe Missions Info days
17 - 18 de Enero de 2023 | Programa
The European Commission announces that the Info Day for the EU Missions will be held as a virtual event on Wednesday 17 and Thursday 18 January 2023.

The Cancer Mission session will be held from 14.00-16.00 on Tuesday 17th January.
The Info Day will present the new calls in the Missions' part of the main Work Programme 2023 under Horizon Europe.

The sessions will give the opportunity to prospective applicants to learn more about the funding options on Missions through a series of dedicated sessions.

All recordings of the event's sessions will be made available on-line for future reference.


IHI Call Days – Call 4 (two stage)
18 - 19 de Enero de 2023 | Registro
The aim of the IHI Call Days is to provide potential applicants with the information they need to put together a strong proposal and give them the opportunity to identify and meet partners for their consortia.

The main activities of the Call Days will be as follows: 
•    Info session on the rules and procedures
•    Info sessions on the call topics

The following topics are under consideration:
•    Topic 1: Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical drug safety assessment
•    Topic 2: Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare

Registration is free but it is mandatory.


Horizon Europe Infoday – Salud
19 de Enero de 2023 | Registro
En horario de 09:00 a 17:10 tendrá lugar el infoday del clúster salud en formato online.

Esta jornada informativa tiene por objeto informar a los candidatos (potenciales) sobre los temas incluidos en el programa de trabajo del Grupo 1 "Salud" de 2023.


Info webinar on the Joint Trasnational Call
26 de Enero de 2023 | Registro | Programa
Increasing health equity through promoting healthy diets and physical activity – “HealthEquity” – 10:00

Following the recent pre-announcement of the HealthEquity call on research targeting health inequalities through promoting healthy diets and physical activity, ERA4Health invites all potential project applicants to an information webinar.

In the webinar, the call documents and guidelines on how to apply for the call will be presented. ERA4Health will also facilitate networking of applicants.

For participation, please register via the link below, until Wednesday January 18, 2023 EOB.

The registration link for the webinar is:


TMEX – Translational Medicine Explained 5 Day Winter School 2023
13 de Febrero de 2023 | Programa
EJP RD – European Joint Programme on Rare Diseases – 13-17/02/2023 12 :00 – 17 :00 Barcelona, Spain

Registration is now open to the yearly 5-day course on “Translational Medicine Explained (TMex) ” on 13-17 February 2023 in Barcelona. The course is intended for PhD/MD students, postdocs and other young scientists who are involved in biomedical research and want to learn more about Translational Medicine.
The TMex  (“Translational Medicine Explained)” Winter School consists of an introductory e learning (~12 hours student investment time) followed by a 5-day face-to-face workshop. The course is intended for PhD/MD students in the second half of their PhD and postdocs who are involved in biomedical research.
The full fee is of 650€. Special discounted fees of 475€ applies for EATRIS members and I2TRON students, and of 250€ for VHIR students and EUPATI fellows.
There are only 30 seats, so we recommend applying early (first come, first served). The registration will close when all seats have been filled. You will need to submit a biosketch and a motivation letter which will be reviewed by a selection committee.


Instituto de Investigación Sanitaria Aragón (IIS Aragón)
Centro de Investigación Biomédica de Aragón (CIBA)
Avda. San Juan Bosco, nº 13. 50009 - Zaragoza
Tfno. +34 976 71 64 17 | +34 976 71 44 02

Recibes este boletín porque eres miembro del IIS Aragón o porque estás interesado en sus actividades. Si no deseas recibirlo, por favor, ponte en contacto con para tramitar la baja de la suscripción.

Free stock photos from